Skip to main content
Loading

Leveraging AI and early structural insights to power rational antibody lead design and optimization

23 Jun 2025
Lead Identification & Optimization
  • Where does AI stand on de novo antibody design? 
  • How can human BCR and single cell sequencing data inform antibody design? 
  • How can AI and structural information enable efficient antibody optimization?
Industry Expert
Xingfeng Bao, VP of Biology - GV20 Therapeutics